These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4358121)

  • 1. Adenovirus vaccines in military recruit populations: a cost-benefit analysis.
    Collis PB; Dudding BA; Winter PE; Russell PK; Buescher EL
    J Infect Dis; 1973 Dec; 128(6):745-52. PubMed ID: 4358121
    [No Abstract]   [Full Text] [Related]  

  • 2. Live and killed adenovirus vaccines for the prevention of acute respiratory disease in recruits.
    Pierce WE; Peckinpaugh RO; Frazier WE; Griffin JP; Greenberg BH; Jackson GG
    Antimicrob Agents Chemother (Bethesda); 1965; 5():55-8. PubMed ID: 4286921
    [No Abstract]   [Full Text] [Related]  

  • 3. Control of respiratory disease in recruits with types 4 and 7 adenovirus vaccines.
    Top FH; Dudding BA; Russell PK; Buescher EL
    Am J Epidemiol; 1971 Aug; 94(2):142-6. PubMed ID: 4327997
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute respiratory disease in military trainees: the adenovirus surveillance program, 1966-1971.
    Dudding BA; Top FH; Winter PE; Buescher EL; Lamson TH; Leibovitz A
    Am J Epidemiol; 1973 Mar; 97(3):187-98. PubMed ID: 4348245
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunization with live types 7 and 4 adenovirus vaccines. II. Antibody response and protective effect against acute respiratory disease due to adenovirus type 7.
    Top FH; Buescher EL; Bancroft WH; Russell PK
    J Infect Dis; 1971 Aug; 124(2):155-60. PubMed ID: 4330998
    [No Abstract]   [Full Text] [Related]  

  • 6. Experience with vaccines--general comments.
    Buescher EL
    Natl Cancer Inst Monogr; 1968 Dec; 29():527-9. PubMed ID: 4305441
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunization with live types 7 and 4 adenovirus vaccines. I. Safety, infectivity, antigenicity, and potency of adenovirus type 7 vaccine in humans.
    Top FH; Grossman RA; Bartelloni PJ; Segal HE; Dudding BA; Russell PK; Buescher EL
    J Infect Dis; 1971 Aug; 124(2):148-54. PubMed ID: 4330997
    [No Abstract]   [Full Text] [Related]  

  • 8. Simultaneous oral administration of live adenovirus types 4 and 7 vaccines. Protection and lack of emergence of other types.
    Gooch WM; Mogabgab WJ
    Arch Environ Health; 1972 Dec; 25(6):388-94. PubMed ID: 4343867
    [No Abstract]   [Full Text] [Related]  

  • 9. Recent experiences with live adenovirus vaccines in navy recruits.
    Rosenbaum MJ; Edwards EA; Hoeffler DF CAPT
    Mil Med; 1975 Apr; 140(4):251-7. PubMed ID: 167324
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunization of Canadian Armed Forces personnel with live types 4 and 7 adenovirus vaccines.
    Chaloner-Larsson G; Contreras G; Furesz J; Boucher DW; Krepps D; Humphreys GR; Mohanna SM
    Can J Public Health; 1986; 77(5):367-70. PubMed ID: 3024797
    [No Abstract]   [Full Text] [Related]  

  • 11. Environmental modifications for controlling acute respiratory disease.
    Lehane DE; Newberg NR; Beam WE
    Am J Epidemiol; 1974 Feb; 99(2):139-44. PubMed ID: 4359271
    [No Abstract]   [Full Text] [Related]  

  • 12. Live and inactivated adenovirus vaccines for the prevention of acute respiratory illness in naval recruits.
    Pierce WE; Rosenbaum MJ; Edwards EA; Peckinpaugh RO; Jackson GG
    Am J Epidemiol; 1968 Jan; 87(1):237-46. PubMed ID: 4295428
    [No Abstract]   [Full Text] [Related]  

  • 13. Control of acute mycoplasmal and viral respiratory tract disease.
    Chanock RM
    Science; 1970 Jul; 169(3942):248-56. PubMed ID: 4317229
    [No Abstract]   [Full Text] [Related]  

  • 14. The minimal infectious dose of adenovirus type 4; the case for natural transmission by viral aerosol.
    Couch RB; Knight V; Douglas RG; Black SH; Hamory BH
    Trans Am Clin Climatol Assoc; 1969; 80():205-11. PubMed ID: 4308674
    [No Abstract]   [Full Text] [Related]  

  • 15. Surveillance snapshot: adenovirus among U.S. military recruit trainees.
    Hawksworth A
    MSMR; 2012 Mar; 19(3):5. PubMed ID: 22452713
    [No Abstract]   [Full Text] [Related]  

  • 16. Vaccination with live type 4 adenovirus: evaluation of antibody response and protective efficacy.
    van der Veen J; Abarbanel MF; Oei KG
    J Hyg (Lond); 1968 Dec; 66(4):499-511. PubMed ID: 4303951
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the preventive effect of amantadine hydrochloride in influenza and other respiratory viral infections].
    Halonen P; Mujunen R; Mäntyjärvi R
    Sotilaslaak Aikak; 1965; 40(4):130-7. PubMed ID: 4286330
    [No Abstract]   [Full Text] [Related]  

  • 18. Mass enteric live adenovirus vaccination during epidemic ARD.
    Peckinpaugh RO; Pierce WE; Rosenbaum MJ; Edwards EA; Jackson GG
    JAMA; 1968 Jul; 205(1):75-80. PubMed ID: 4298134
    [No Abstract]   [Full Text] [Related]  

  • 19. Combinations of Asian influenza virus and adenovirus vaccine in the prophylaxis of respiratory illness of Navy recruits. II.
    STILLE WT; SCHULTZ I; GUNDELFINGER BF; MILLER LF
    Am J Public Health Nations Health; 1962 Feb; 52(2):275-89. PubMed ID: 13917238
    [No Abstract]   [Full Text] [Related]  

  • 20. II. EFFICACY OF ADJUVANT AND AQUEOUS ADENOVIRUS VACCINES IN PREVENTION OF NAVAL RECRUIT RESPIRATORY DISEASE.
    MILLER LF; PECKINPAUGH RO; ARLANDER TR; PIERCE WE; EDWARDS EA; DEBERRY P; PHILLIPS IA; ROSENBAUM MJ
    Am J Public Health Nations Health; 1965 Jan; 55(1):47-59. PubMed ID: 14246107
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.